All News
Filter News
Found 2,297 articles
-
Human Vaccines Project Release: New Study Aims To Explain The Rules Of How The Immune System Works
5/8/2017
-
Jose-Maria Fernandez Joins The Human Vaccines Project Board Of Directors
5/4/2017
-
Melissa J. Moore, Ph.D., Chief Scientific Officer, mRNA Research Platform At Moderna, Elected To National Academy of Sciences
5/3/2017
-
Biotech Unicorn Moderna's Vaccine Performs Well in First Human Trial
5/1/2017
-
Moderna Announces Positive Interim Phase I Clinical Data Demonstrating First mRNA Vaccine Candidate, mRNA-1440, Induces High Levels Of Immunogenicity
4/27/2017
-
Arbutus Biopharma Injunction Survives Attempted Appeal By Acuitas Therapeutics
4/13/2017
-
The Human Vaccines Project, Vanderbilt University And Illumina Join Forces To Decode The Human Immunome
4/11/2017
-
Revolution Medicines Appoints Cancer Leader Dr. Stephen Kelsey As President Of Research And Development
3/20/2017
-
Moderna's Oncology Boss Reportedly Leaving Company
2/22/2017
-
Moderna Appoints Israel Ruiz To Its Board Of Directors
2/22/2017
-
5 Best U.S. Regions for Life Science Jobs
2/21/2017
-
Why Secretive $5 Billion Biotech Moderna May Not be Able to Commercialize Products Into Clinical Trials
2/16/2017
-
Arbutus Biopharma Is Granted A Pre-Trial Injunction Restraining Acuitas From Entering Into Agreements Sublicensing Arbutus LNP Technology
2/8/2017
-
DPS Announces Appointment Of Aidan O'Dwyer, President Of U.S. Project Operations, Life Sciences Division
2/1/2017
-
Charles River Laboratories Announces Progress Update For Collaboration With Moderna
1/30/2017
-
What You Need to Know About Neon Therapeutics
1/12/2017
-
JPM17: CureVac Release: Biotech's mRNA Program Fails Phase II Test, Putting Spotlight on Other Biotechs Like Moderna
1/12/2017
-
JPM17: Secretive Moderna Finally Unveils Pipeline, Financials
1/11/2017
-
JPM17: Vertex Game Plan for Growth in 2017
1/10/2017
-
13 Reasons to Watch the J.P. Morgan Healthcare Conference Next Week
1/6/2017